Clinical efficacy of percutaneous interstitial brachytherapy for peripheral non-small cell lung cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002715

Enrollment

Unknown

Registered

2012-11-23

Start date

2012-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral non-small cell lung cancer

Interventions

1:electrical stimulate

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with definite pathological diagnosis of peripheral non-small cell lung cancer, staging ?b; 2. 18 ~ 80 years age; 3. No radiotherapy contraindications, 6 months survival after radiotherapy; 4. ECOG02; 5. No other serious diseases that can affect this treatment; 6. Non-pregnant or lactating women; 7. Volunteered as subjects and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients of the T4 in clinical stage III B; 2. Lesions located in bronchial beam within 2cm; 3. Clear with other severe diseases befoure treatment; 4. Merge with AIDS and active syphilis.

Design outcomes

Primary

Measure	Time frame
short-term efficacy;toxicity;Survival rate;	—

Countries

China

Contacts

Public ContactWujing Bo

wjb6417@163.com+86 13980257136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026